ArticleHuman vaccines & immunotherapeutics2022
COVID-19 vaccine willingness prior to and during the COVID-19 vaccination rollout in Australia.
Article in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 12 citations in OpenAlex.
- Using Aboriginal participatory action research within a mixed methods study exploring COVID-19 vaccination uptake in Aboriginal women: a methodological framework for co-design.Frontiers in global women's health · 2026Article
- Recognising the heterogeneity of Indigenous Peoples during the COVID-19 pandemic: a scoping review across Canada, Australia, New Zealand and the USA.BMJ public health · 2024Article
- Article
- Perceptions and attitudes toward COVID-19 vaccination among health professional students in Australia: a qualitative study.Journal of public health policy · 2024Article
- Having a real say: findings from first nations community panels on pandemic influenza vaccine distribution.BMC public health · 2023Article
- Factors associated with COVID-19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: a cross-sectional study.BMC public health · 2022Article
- Determinants of Actual COVID-19 Vaccine Uptake in a Cohort of Essential Workers: An Area-Based Longitudinal Study in the Province of Prato, Italy.International journal of environmental research and public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to assess vaccine willingness, and the reasons why respondents were not likely to receive COVID-19 vaccine prior to and during the COVID-19 vaccine rollout. This cross-sectional survey (n = 5,130) was conducted between January and April 2021 in South Australia, Australia. Weighted multiple logistic regression was performed to assess the association between sociodemographic/health factors and outcome measures. The percentage of respondents who stated they were very likely to get vaccinated fluctuated between 50% and 78% during the survey period. The willingness of receiving COVID-19 vaccination was significantly lower among women than men (aOR: 0.70) and higher among adults ≥50 years (aOR: 1.82 for 50-69 years and aOR: 3.01 for ≥70 years vs 16-29-year olds). Other factors significantly associated with higher willingness were ≥Year 12 education (aOR: 2.50 for Year 12/TAFE/certificate/diploma vs <Year 12 education; aOR: 1.44 for bachelor's degree or higher vs <Year 12 education), highest socioeconomic level vs lowest socioeconomic level (aOR: 1.75), and unpaid work/retirement/other vs unemployment (aOR: 1.77). Other factors such as being Aboriginal, not being married, not having chronic illness, and/or culturally and linguistically diverse backgrounds were identified to be significantly related to low confidence in vaccine safety, perceived low risk of disease and/or perceived lack of information. Parents or caregivers were significantly less willing for their child to be vaccinated compared to people in general (OR: 0.62). Targeted campaigns to improve uptake need to include appropriate messaging about vaccine safety and disease burden in addition to strategies to improve access to less willing groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.